WeVote
Log In

Bill

Bill

S 10260

Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state

2025 Regular Session Introduced by Kevin Parker and 1 co-sponsor

Expands New York’s newborn screening to include five lysosomal storage diseases, enabling earlier detection and timely treatment for affected infants.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · S 10260

Bill Summary: S 10260 (2025-2026) – Adds CLN2, MPS IVA, MPS VI, MPS VII, and Fabry Diseases to the New York Newborn Screening Panel

Purpose and intent

  • The bill seeks to expand New York State’s newborn screening program by adding five specific lysosomal storage diseases to the state’s mandatory newborn screening panel: CLN2 disease, MPS IVA (Morquio A syndrome), MPS VI (Maroteaux-Lamy syndrome), MPS VII (Sly syndrome), and Fabry disease.
  • The goal is early identification of these conditions to enable timely medical intervention, improve health outcomes, and reduce disease-associated morbidity and mortality.

Key provisions and changes

  • Expansion of screening panel: Requires including the five listed diseases in the newborn screening panel administered by the state.
    • CLN2 disease (neuronopathic Batten disease type 2)
    • MPS IVA (Morquio A)
    • MPS VI (Maroteaux-Lamy)
    • MPS VII (Sly syndrome)
    • Fabry disease
  • Authority and administration: Presumably places responsibilities on the relevant state health department or newborn screening program to implement the additional tests, ensure laboratory capacity, reporting, confirmatory testing protocols, and follow-up procedures (the exact procedural language is not provided in the summary but would typically cover specimen collection, testing methodology, confirmatory testing, and reporting timelines).
  • Follow-up and care pathways: Likely requires establishing confirmatory testing, diagnostic workups, and referral processes for infants who screen positive, including access to clinical care and potential treatment options.
  • Implementation timeline: The bill would set a timeline for implementation, including when the additional screenings would become mandatory, and any phased-in approach. ( precise dates would be defined in the full text.)

Who is affected

  • Newborns and families in New York State: All newborns would be screened for the additional five diseases as part of standard newborn screening, enabling early detection.
  • Healthcare providers and newborn screening laboratories: Hospitals, birthing centers, and public health laboratories would need to adopt testing for the new conditions, update protocols, and coordinate confirmatory testing and care.
  • State health infrastructure: The New York State Department of Health and related agencies would oversee policy, testing standards, data reporting, and follow-up care pathways.

Procedural and timeline considerations

  • Legislative process: As of the latest action history, the bill was referred to the Health Committee (2026-05-08). Further committee actions, approvals, and potential amendments would determine its progression toward enactment.
  • Funding and resources: Implementation would require evaluating costs for laboratory testing, confirmatory diagnostics, confirmatory testing, medical follow-up, and potential treatment access, along with any needed staffing and equipment upgrades.
  • Quality and ethics considerations: Expansion of screening often involves balancing false positives/false negatives, parental consent considerations for test results, and data privacy and follow-up care commitments.

Practical impact

  • Early detection of the five diseases can lead to timelier medical interventions, which may include enzyme replacement therapies, supportive therapies, or other disease-modifying treatments where available.
  • Improved long-term outcomes and potential reduction in disease burden for affected individuals and families.

If you would like, I can tailor this summary to include the specific statutory language, anticipated funding provisions, or a comparison with current NY newborn screening timelines and capabilities once the full bill text is available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.